Products

Primary tabs

Export products to Excel

Displaying 196 - 210 of 212
Target: Female
Mode: Hormonal
Delivery Type: Subdermal
Project Stage: Marketed
Alternative Name: Ulipristal acetate (UPA) Intrauterine System (IUS)
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Intrauterine
Project Stage: Pre-clinical
Alternative Name: Ulipristal acetate (UPA) vaginal ring
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Phase II
Alternative Name: S-003296
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel
Project Stage: Pre-clinical
Alternative Name: Vas deferens polymer contraceptive
Development Status: Active Development
Target: Male
Mode: Non-hormonal
Delivery Type: Vas Deferens
Project Stage: Pre-clinical
Development Status: SRA/WHO PQ Approved
Target: Female
Mode: Non-hormonal
Delivery Type: Barrier
Project Stage: Marketed
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Intrauterine
Project Stage: Phase II
Partner: ContraMed, LLC
Development Status: Active Development
Target: Female
Mode: Hormonal
Delivery Type: Vaginal Ring
Project Stage: Pre-clinical
Partner: DAIDS, Merck, NIAID
Alternative Name: WEE1 HOMOLOG 2, WEE1B, WEE2 Kinase
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: TBD
Project Stage: Lead Optimization
Alternative Name: PPCM Vaginal Gel
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel, Vaginal, Other
Project Stage: Pre-clinical
Alternative Name: Miglustat, N-butyldeoxynojirimycin (NB-DNJ)
Development Status: Inactive
Target: Male
Mode: Non-hormonal
Delivery Type: Oral
Development Status: Active Development
Target: Female
Mode: Non-hormonal
Delivery Type: Vaginal Gel
Project Stage: Target ID/Validation
Export to Excel